Ticker Details
Roivant Sciences Ltd. Common Shares
IPO Date:	January 1, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$26.48B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.30 | 2.88%
Avg Daily Range (30 D):	$0.64 | 2.06%
Avg Daily Range (90 D):	$0.68 | 2.33%

Institutional Daily Volume
Avg Daily Volume:	3.16M
Avg Daily Volume (30 D):	4.55M
Avg Daily Volume (90 D):	4.42M

Trade Size
Avg Trade Size (Sh.):	138
Avg Trade Size (Sh.) (30 D):	87
Avg Trade Size (Sh.) (90 D):	90

Institutional Trades
Total Institutional Trades:	4,574
Avg Institutional Trade:	$4.35M
Avg Institutional Trade (30 D):	$5.75M
Avg Institutional Trade (90 D):	$6.57M
Avg Institutional Trade Volume:	.29M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$12.16M
Avg Closing Trade (30 D):	$37.43M
Avg Closing Trade (90 D):	$31.17M
Avg Closing Volume:	826.44K

News

May 18, 2026 @ 5:00 PM Myasthenia Gravis Market Set to Surpass USD 16 Bil... Source: Delveinsight

Apr 15, 2026 @ 5:00 PM Generalized Myasthenia Gravis Market on the Brink ... Source: Delveinsight

Apr 2, 2026 @ 9:00 AM Priovant Expands Brepocitinib Development Program ... Source: Na

Mar 28, 2026 @ 7:00 PM New England Journal of Medicine Publishes Positive... Source: Priovant Therapeutics / Roivant Sciences

Mar 5, 2026 @ 7:42 PM 9 Biotech Stocks Trading Far Below Fair Value With... Source: David Wagner

Financials
	TTM	Q4 2026	FY 2026
Basic EPS	$-.43	$.45	$-.43
Diluted EPS	$-.54	$.34	$-.54
Revenue	$8.26M	$2.52M	$8.26M
Gross Profit
Net Income / Loss	$-397.91M	$355.74M	$-397.91M
Operating Income / Loss	$-515.07M	$415.24M	$-515.07M
Cost of Revenue
Net Cash Flow	$-1298.45M	$-59.1M	$-1298.45M
PE Ratio